Merck KGaA (MRK) Price & Analysis

Compare

154 Followers

MRK Stock Chart & Stats

€119.30

-€0.25(-0.17%)

At close: Jan 09 4:00 PM EST

€119.30

-€0.25(-0.17%)

Day’s Range― - ―

52-Week Range€100.70 - €154.65

Previous CloseN/A

Volume8.13K

Average Volume (3M)321.00K

Market Cap

€51.87B

Enterprise Value€55.88B

Total Cash (Recent Filing)€2.92B

Total Debt (Recent Filing)€12.10B

Price to Earnings (P/E)17.5

Beta0.84

Next Earnings

Mar 05, 2026

EPS Estimate

1.95

Next Dividend Ex-DateN/A

Dividend Yield1.84%

Share Statistics

EPS (TTM)2.32

Shares Outstanding129,242,250

10 Day Avg. Volume344,164

30 Day Avg. Volume321,004

Financial Highlights & Ratios

PEG Ratio-12.94

Price to Book (P/B)2.03

Price to Sales (P/S)2.88

P/FCF Ratio25.32

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€140.57

Price Target Upside17.83% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering8

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Electronics DivisionElectronics recovery is playing out due to AI, improving the profile of the division.

Growth ExpectationsA return to growth in Life Sciences and Process Solutions for the first time in five quarters is expected to give additional confidence to investors on future growth expectations.

ValuationAnalyst re-iterates BUY as MRK is attractively valued compared to its end markets and peers.

Bears Say

EBITDA QualityThere is a negative perception surrounding Healthcare-driven EBITDA beats due to cost releases, which investors might see as lower quality compared to topline-driven growth.

Life Sciences ChallengesThere is a clear lack of visibility on FY25 Life Sciences trends, with Bioprocessing numbers below mid-term expectations.

Sales ExpectationsThe guidance indicates that the upper end of the sales range is out of reach, aligning with previous messaging but possibly disappointing investors hoping for higher sales figures.

Merck KGaA News

Merck KGaA price target lowered to EUR 150 from EUR 155 at JPMorgan

JPMorgan lowered the firm’s price target on Merck KGaA (MKKGY) to EUR 150 from EUR 155 and keeps...

13d ago

Cautious Outlook for Merck KGaA Amidst Unchanged Guidance and Growth Concerns

In a report released today, Dylan Van Haaften from Stifel Nicolaus maintained a Sell rating on Merck KGaA,...

1M ago

0O14 Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Merck KGaA (0O14) is scheduled to report 3rd quarter earnings on 11/13/2025, before the market opens. Regarding Q3...

1M ago

Universal Display to acquire emissive OLED patent assets from Merck KGaA

Universal Display (OLED) announced that it has entered into a definitive agreement to acquire OLED patent assets from...

1M ago

OLED

Merck KGaA: Strategic Growth Amidst Challenges Supports Buy Rating

In a report released today, Dylan Van Haaften from Stifel Nicolaus maintained a Buy rating on Merck KGaA...

7M ago

0O14 Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Merck KGaA (0O14) is scheduled to report 1st quarter earnings on 05/15/2025, before the market opens. Regarding Q1...

7M ago

Merck KGaA (0O14) Discloses Q2 Dividend: What Shareholders Should Know

Merck KGaA (LSE: 0O14) has declared, under its dividend policy, a yearly cash dividend in the amount of...

9M ago

0O14 Upcoming Earnings Report: What to Expect?

Merck KGaA (0O14) is scheduled to report 4th quarter earnings on 03/06/2025, before the market opens. Regarding Q4...

10M ago

0O14 Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Merck KGaA (0O14) is scheduled to report 3rd quarter earnings on 11/14/2024, before the market opens. Regarding Q3...

1y ago

Is 0O14 a Buy, Before Earnings?

Merck KGaA (0O14) is scheduled to report 1st quarter earnings on 05/15/2024, before the market opens. Regarding Q1...

2y ago

Merck KGaA (0O14) Declares Q2 Dividend: Important Details for Shareholders

Merck KGaA (LSE: 0O14) has declared, under its dividend policy, a yearly cash dividend in the amount of...

2y ago

Merck KGaA (0O14) Q4 Earnings Cheat Sheet

Merck KGaA (0O14) is scheduled to report 4th quarter earnings on 03/07/2024, before the market opens. Regarding Q4...

2y ago

MRK FAQ

What was Merck KGaA’s price range in the past 12 months?

Merck KGaA lowest stock price was €100.70 and its highest was €154.65 in the past 12 months.

What is Merck KGaA’s market cap?

Merck KGaA’s market cap is €51.87B.

When is Merck KGaA’s upcoming earnings report date?

Merck KGaA’s upcoming earnings report date is Mar 05, 2026 which is in 74 days.

How were Merck KGaA’s earnings last quarter?

Merck KGaA released its earnings results on Nov 13, 2025. The company reported €2.32 earnings per share for the quarter, beating the consensus estimate of €2.206 by €0.114.

Is Merck KGaA overvalued?

According to Wall Street analysts Merck KGaA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Merck KGaA pay dividends?

Merck KGaA pays a Annually dividend of €2.2 which represents an annual dividend yield of 1.84%. See more information on Merck KGaA dividends here

What is Merck KGaA’s EPS estimate?

Merck KGaA’s EPS estimate is 1.95.

How many shares outstanding does Merck KGaA have?

Merck KGaA has 129,242,250 shares outstanding.

What happened to Merck KGaA’s price movement after its last earnings report?

Merck KGaA reported an EPS of €2.32 in its last earnings report, beating expectations of €2.206. Following the earnings report the stock price went up 4.97%.

Which hedge fund is a major shareholder of Merck KGaA?

Currently, no hedge funds are holding shares in DE:MRK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Merck KGaA Stock Smart Score

Neutral

Fundamentals

Return on Equity

10.32%

Trailing 12-Months

Asset Growth

-5.06%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Merck KGaA

Merck KGaA, Darmstadt, Germany, is a global science and technology company that operates in the healthcare, life science, and performance materials sectors. The company is dedicated to developing innovative solutions to improve the health and quality of life of people worldwide. Its core products include pharmaceuticals, biopharmaceuticals, and specialty chemicals, with strong emphasis on areas such as oncology, neurology, and fertility treatments. Additionally, Merck KGaA offers laboratory materials and services, as well as high-tech materials for various industries, including electronics and cosmetics.

Merck KGaA (MRK) Earnings & Revenues

Historic Earnings Reports

MRK Stock 12 Month Forecast

Average Price Target

€140.57

▲(17.83% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"104":"€104","183":"€183","123.75":"€123.8","143.5":"€143.5","163.25":"€163.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":182,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€182.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":140.57,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€140.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":105,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€105.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[104,123.75,143.5,163.25,183],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,116.65,121.67692307692309,126.70384615384616,131.73076923076923,136.7576923076923,141.7846153846154,146.81153846153848,151.83846153846156,156.8653846153846,161.8923076923077,166.91923076923078,171.94615384615383,176.97307692307692,{"y":182,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,116.65,118.49000000000001,120.33,122.17,124.01,125.85,127.69,129.53,131.37,133.21,135.05,136.89,138.73,{"y":140.57,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,116.65,115.75384615384615,114.85769230769232,113.96153846153847,113.06538461538462,112.16923076923078,111.27307692307693,110.37692307692308,109.48076923076923,108.58461538461539,107.68846153846154,106.79230769230769,105.89615384615385,{"y":105,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":139.274,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.359,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.741,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.579,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.301,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":114.75,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.4,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107.15,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.7,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":120.45,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":113.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":116.65,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >